Irritable Bowel Syndrome (IBS) Diagnostics Market Scope 2031
Irritable Bowel Syndrome (IBS) Diagnostics Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2020 | US$ 2.47 Billion |
| Market Size by 2028 | US$ 3.88 Billion |
| Global CAGR (2020 - 2028) | 5.9% |
| Historical Data | 2018-2019 |
| Forecast period | 2021-2028 |
| Segments Covered |
By Diagnosis
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
Irritable Bowel Syndrome (IBS) Diagnostics – Market Segmentation
By Diagnosis
- Laboratory Tests
- Lactose Intolerance Tests
- Breath Test for Bacterial Overgrowth
- Stool Tests
- Blood Tests
- Imaging Tests
- CT Scan or X-Ray
- Upper Endoscopy
- Colonoscopy
By Indication
- Pain and Cramping
- Diarrhea
- Constipation
- Alternating Constipation and Diarrhea
By Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- UK
- Italy
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
Middle East & Africa (MEA)
- Saudi Arabia
- South Africa
- UAE
- Rest of Middle East & Africa
South and Central America (SCAM)
- Brazil
- Argentina
- Rest of South and Central America
Company Profiles
- Commonwealth Diagnostics International
- Genova Diagnostics
- Gemelli Biotech
- Prometheus Laboratories
- Inova Diagnostics, Inc.
- Biohit Oyj
- Aerodiagnostics, LLC.
- Metabolic Solutions, Inc.
- Sysmex Corporation
- Bühlmann Laboratories AG
Get Free Sample For